NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

LAWRENCE, Mass., Oct. 18, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, announced new findings demonstrating ...

LAWRENCE, Mass., Aug. 4, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, joins over one hundred NxStage patients in ...

NxStage Medical, Inc.NXTM recently announced the receipt of CE mark for its NxGen Hemodialysis System, an innovative device with easier user interface and integrated blood pressure monitor system for ...

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

Please provide your email address to receive an email when new articles are posted on . NxStage Medical Inc. is celebrating its 10th year anniversary this summer of the Food and Drug Administration's ...

Please provide your email address to receive an email when new articles are posted on . NxStage Medical Inc.’s next generation System One hemodialysis system has received the CE mark in Europe. The ...

NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, today announced that the NxStage® System One™ is now used in eight of the Top 10 Nephrology Hospitals in the United ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Just days after naming a new executive to handle ...

NxStage Medical, a leading medical technology company focused on advancing renal care, has announced that its next generation hemodialysis system has received CE Mark approval. This innovative system ...